Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 8 de 8 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Huizinga P, Kluytmans-van den Bergh M, van Rijen M, Willemsen I, van't Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase-producing enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361-3. [Ref.ID 101508]
2. Cita con resumen
Hawkey PM, Livermore DM. Carbapenem antibiotics for serious infections. BMJ 2012;344:43-7. [Ref.ID 93298]
3.
Schwaber MJ, Carmeli Y. Carbapenem-resistant enterobacteriaceae. A potential threat. JAMA 2008;300:2911-3. [Ref.ID 84836]
4.
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae. Arch Intern Med 2005;165:1375-80. [Ref.ID 74315]
5. Cita con resumen
File Jr TM. Community-acquired pneumonia. Lancet 2003;362:1991-2001. [Ref.ID 68472]
6.
Ibarburu Valbuena I, Labraca Sánchez J, Lerma Lucas M, Solanas Mateo B. Infecciones del tracto urinario en atención primaria. Aten Primaria 2000;26:65. [Ref.ID 51187]
7.Tiene citas relacionadas Cita con resumen
Reacher M H, Shah A, Livermore DM, Wale MCJ, Graham C, Johnson AP, Heine H, Monnickendam MA, Barker KF, James D, George RC. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-6. [Ref.ID 48972]
8.
Anónimo. The choice of antibacterial drugs. Med Lett Drugs Ther 1998;40:33-42. [Ref.ID 38490]
Seleccionar todas
 
 1 a 8 de 8